Medications
Pfizer to spend $11.6B on migraine treatment maker Biohaven
Pfizer is spending $11.6 billion to buy the remaining portion of migraine treatment maker Biohaven Pharmaceuticals it does not already own.
May 10, 2022
0
0
News tagged with pfizer
Overweight & Obesity
Study suggests severe obesity blunts antibody response to COVID-19 vaccines
New research being presented at this year's European Congress on Obesity (ECO) in Maastricht, Netherlands (4-7 May), suggests that adults (aged 18 or older) with severe obesity generate a significantly weaker immune response ...
May 6, 2022
0
4
Vaccination
FDA restricts J&J's COVID-19 vaccine due to blood clot risk
U.S. regulators on Thursday strictly limited who can receive Johnson & Johnson's COVID-19 vaccine due to the ongoing risk of rare but serious blood clots.
May 5, 2022
0
48
Pediatrics
Only 1 in 5 parents plan to get COVID vaccine for kids under 5 when available
Only 18 percent of parents of children under 5 say they plan to get their child vaccinated against COVID as soon as they can, while nearly 4 in 10 say they will "wait and see" before getting shots for their child, a new U.S. ...
May 4, 2022
0
4
Other
Pfizer Q1 revenues jump 77% to $25.7 bn on Covid-19 vaccine
Pfizer reported another quarter of huge revenues growth because of its COVID-19 vaccine on Tuesday, but lowered the company's full-year profit forecast due in part to shifts in foreign exchange.
May 3, 2022
0
0
Medications
Pfizer sees high demand for COVID-19 pill as profits jump
Pfizer executives said Tuesday they are confident of strong demand for the company's COVID-19 antiviral treatment amid easing pandemic rules as the big drugmaker reported another round of strong earnings.
May 3, 2022
0
5
Vaccination
Pfizer hopes to submit little-kid vaccine data by early June
Pfizer now hopes to tell U.S. regulators how well its COVID-19 vaccine works in the littlest kids by late May or early June.
May 3, 2022
0
2
Pediatrics
Pfizer seeks FDA approval of COVID-19 boosters for children ages 5 to 11
Pfizer Inc. announced Tuesday that it has asked the U.S. Food and Drug Administration to approve emergency use of its booster shot for children ages 5 to 11 years.
Apr 28, 2022
0
7
Vaccination
Pfizer to seek COVID booster for healthy 5- to 11-year-olds
Pfizer said Thursday it wants to expand its COVID-19 booster shots to healthy elementary-age kids.
Apr 14, 2022
0
5
Diseases, Conditions, Syndromes
Fourth COVID shot provides little benefit against Omicron infection: study
A fourth dose of existing mRNA COVID-19 vaccines may have only "marginal benefits" for younger, healthy adults, according to a new Israeli study published Wednesday in the New England Journal of Medicine.
Mar 16, 2022
0
479
